STOCK TITAN

Intercept to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq:ICPT) has announced that Jerry Durso, President and CEO, will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 14, 2021, at 11:40 a.m. ET. The event will be available via a live webcast on the investor page of Intercept’s website, with an audio archive accessible for two weeks following the event.

Intercept focuses on developing therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.

Positive
  • None.
Negative
  • None.

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Thursday, January 14, 2021 at 11:40 a.m. ET.

A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

   Investor inquiries:  investors@interceptpharma.com      

   Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.


FAQ

When will Intercept Pharmaceuticals present at the J.P. Morgan Virtual Healthcare Conference?

Intercept Pharmaceuticals will present on January 14, 2021, at 11:40 a.m. ET.

Who is presenting for Intercept Pharmaceuticals at the upcoming conference?

Jerry Durso, the President and CEO of Intercept Pharmaceuticals, will present.

How can I watch the Intercept Pharmaceuticals presentation?

The presentation can be viewed via a live webcast on Intercept’s investor page.

What is the main focus of Intercept Pharmaceuticals?

Intercept Pharmaceuticals focuses on developing therapeutics for progressive non-viral liver diseases.

What are some diseases Intercept Pharmaceuticals targets?

Intercept targets primary biliary cholangitis and nonalcoholic steatohepatitis.

Intercept Pharmaceuticals, Inc.

NASDAQ:ICPT

ICPT Rankings

ICPT Latest News

ICPT Stock Data

794.69M
40.45M
3.13%
81.3%
24.24%
Biotechnology
Healthcare
Link
United States
Morristown